Botswana Vaccine Institute (BVI) sales are riding the crest of a wave, so why isn’t the company CEO Andrew Madeswi rubbing his palms gleefully in appreciation of a bumper season?
BVI’s foot and mouth vaccines are being snapped up even before they leave the production line as the booming regional market maintain a year-long breakneck sales record.
In the six months between March and September 2025, Madeswi sold over 900,000 FMD vaccine doses for about R72 million to South Africa alone, to manage major outbreaks.
There's more to this story
But to keep reading, we need you to subscribe.
Investigative journalism is an indispensable part of a healthy society, but it's also expensive to produce. We are reliant on subscriptions to fund our work, and while you can enjoy most of our stories for free, a small number of premium features are reserved for subscribers.
You can subscribe for one week, a month or a full year - the choice is yours.
Save 77% on an annual subscription. Click here to find out how.
Existing subscribers can log in to keep reading here.
